Achromobacter xylosoxidans infection in cystic fibrosis siblings with different outcomes: Case reports

scientific article (publication date: 2017)

Achromobacter xylosoxidans infection in cystic fibrosis siblings with different outcomes: Case reports is …
instance of (P31):
case reportQ2782326
scholarly articleQ13442814

External links are
P356DOI10.1016/J.RMCR.2017.01.005
P932PMC publication ID5256675
P698PubMed publication ID28138423

P50authorRodolpho M. AlbanoQ21391201
Agnaldo José LopesQ57414933
Robson Souza LeãoQ80339947
P2093author name stringVagner Bernardo
Tania Wrobel Folescu
Domenico Capone
Pedro Daltro
Elenice Rosa Aguiar Rodrigues
Elizabeth Andrade Marques
Mônica Cássia Firmida
Rosana Helena Vicente Pereira
P2860cites workInorganic polyphosphate is needed for swimming, swarming, and twitching motilities of Pseudomonas aeruginosaQ24676026
Pseudomonas aeruginosa Evolutionary Adaptation and Diversification in Cystic Fibrosis Chronic Lung InfectionsQ26768034
Increasing awareness of sex differences in airway diseasesQ26775074
A multilocus sequence typing scheme implies population structure and reveals several putative novel Achromobacter speciesQ30524226
Epidemiology and resistance of Achromobacter xylosoxidans from cystic fibrosis patients in Dijon, Burgundy: first French dataQ30560941
Taxonomic dissection of Achromobacter denitrificans Coenye et al. 2003 and proposal of Achromobacter agilis sp. nov., nom. rev., Achromobacter pestifer sp. nov., nom. rev., Achromobacter kerstersii sp. nov. and Achromobacter deleyi sp. nov.Q31112012
Consensus on the use and interpretation of cystic fibrosis mutation analysis in clinical practiceQ33608587
Achromobacter xylosoxidans respiratory tract infection in cystic fibrosis patientsQ35094033
Achromobacter xylosoxidans: characterization of strains in Brazilian cystic fibrosis patientsQ35273711
Gender differences in outcomes of patients with cystic fibrosisQ35641585
Pulmonary disease assessment in cystic fibrosis: comparison of CT scoring systems and value of bronchial and arterial dimension measurementsQ35738208
Characterization of Achromobacter Species in Cystic Fibrosis Patients: Comparison of bla(OXA-114) PCR Amplification, Multilocus Sequence Typing, and Matrix-Assisted Laser Desorption Ionization-Time of Flight Mass SpectrometryQ35786149
Clinical impact of Achromobacter xylosoxidans colonization/infection in patients with cystic fibrosis.Q36688818
Enterococcal surface protein, Esp, enhances biofilm formation by Enterococcus faecalisQ37523948
Outbreak of Achromobacter xylosoxidans in an Italian Cystic fibrosis center: genome variability, biofilm production, antibiotic resistance, and motility in isolated strainsQ37695294
A review of pathophysiology and management of fetuses and neonates with meconium ileus for the pediatric surgeonQ38002221
Effect of estrogen on pseudomonas mucoidy and exacerbations in cystic fibrosisQ38011211
Scoring of chest CT in children with cystic fibrosis: state of the art.Q38244027
Bacterial Adaptation during Chronic Respiratory Infections.Q38367560
Cystic Fibrosis: Microbiology and Host ResponseQ38911644
Unraveling the complex genetic model for cystic fibrosis: pleiotropic effects of modifier genes on early cystic fibrosis-related morbiditiesQ44314873
Intrapatient diversity of Achromobacter spp. involved in chronic colonization of Cystic Fibrosis airways.Q46756421
Marked increase in incidence of Achromobacter xylosoxidans infections caused by sporadic acquisition from the environment.Q51015868
Evaluation of a new definition for chronic Pseudomonas aeruginosa infection in cystic fibrosis patients.Q52858669
Persistent colonization of nine cystic fibrosis patients with an Achromobacter (Alcaligenes) xylosoxidans clone.Q53900736
Cystic fibrosis: scoring system with thin-section CTQ57757613
Inflammation in Achromobacter xylosoxidans infected cystic fibrosis patientsQ59139106
Quantification of biofilm in microtiter plates: overview of testing conditions and practical recommendations for assessment of biofilm production by staphylococciQ59302124
P407language of work or nameEnglishQ1860
P921main subjectsiblingQ31184
cystic fibrosisQ178194
Achromobacter xylosoxidansQ16824899
P304page(s)98-103
P577publication date2017-01-01
P1433published inRespiratory medicine case reportsQ27724736
P1476titleAchromobacter xylosoxidans infection in cystic fibrosis siblings with different outcomes: Case reports
P478volume20

Reverse relations

Q64097453Metabolic Modeling of Cystic Fibrosis Airway Communities Predicts Mechanisms of Pathogen Dominancecites workP2860

Search more.